Direct oral anticoagulants (DOACs) came onto the market only recently, but are widely prescribed, displacing drugs that have been available since the 1950s. Jose Nery, a Safe Medication Management Fellow with the Institute for Safe Medication Practices (ISMP), discusses errors related to DOACs reported to ECRI and the ISMP Patient Safety Organization, and strategies that pharmacists and patients can use to limit those risks.